InNexus Biotechnology, Inc.
InNexus Biotechnology, Inc. (IXSBF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · IXSBF · as of Jun 9, 2026
Key Statistics
Explore InNexus Biotechnology, Inc. Data
ixsbf stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
ixsbf competitorsIXSBF
BMGP
NNLX
ORHB
OZYMF
PXMDStock Performance
Full HistoryAbout InNexus Biotechnology, Inc.
InNexus Biotechnology, Inc. is a development-stage company dedicated to advancing and commercializing monoclonal antibodies. Its efforts are underpinned by its proprietary Dynamic Cross Linking (DXL) …
what is innexus biotechnology, inc. · ixsbf stock overview · innexus biotechnology, inc. company profile · who is innexus biotechnology, inc. ceo · ixsbf OTC · innexus biotechnology, inc. headquarters · innexus biotechnology, inc. business segments
About Stock Overview & Key Data
InNexus Biotechnology, Inc. (IXSBF) is a Healthcare company in the Medical - Pharmaceuticals industry, listed on OTC since Jan 28, 2005. As of the latest trading session, IXSBF stock price is $0.00, with a market capitalization of $12,627. The stock has returned +0.00% over the past 12 months and +0.00% year-to-date.
In fiscal year 2010, InNexus Biotechnology, Inc. reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, InNexus Biotechnology, Inc. (IXSBF) stock price is $0.00. The stock is traded on OTC under the ticker symbol IXSBF. The 52-week range is $0.00 – $0.00.